Normalization of organ bath contraction data for tissue specimen size: does one approach fit all?


Journal

Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264

Informations de publication

Date de publication:
02 2020
Historique:
received: 24 07 2019
accepted: 02 09 2019
pubmed: 13 9 2019
medline: 5 1 2021
entrez: 13 9 2019
Statut: ppublish

Résumé

Organ bath experiments are a key technology to assess contractility of smooth muscle. Despite efforts to standardize tissue specimen sizes, they vary to a certain degree. As it appears obvious that a larger piece of tissue should develop greater force, most investigators normalize contraction data for specimen size. However, they lack agreement which parameter should be used as denominator for normalization. A pre-planned analysis of data from a recent study was used to compare denominators used for normalization, i.e., weight, length, and cross-sectional area. To increase robustness, we compared force with denominator in correlation analysis and also coefficient of variation with different denominators. This was done concomitantly with urinary bladder strips and aortic rings and with multiple contractile stimuli. Our urinary bladder data show that normalization for strip weight yielded the tightest but still only moderate correlation (e.g., r

Identifiants

pubmed: 31511953
doi: 10.1007/s00210-019-01727-x
pii: 10.1007/s00210-019-01727-x
doi:

Substances chimiques

Phenylephrine 1WS297W6MV
Potassium Chloride 660YQ98I10
Carbachol 8Y164V895Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-251

Références

FASEB J. 2018 Apr;32(4):2095-2109
pubmed: 29229685
Br J Pharmacol. 1996 May;118(1):115-22
pubmed: 8733583
Naunyn Schmiedebergs Arch Pharmacol. 2005 Jul;372(1):71-8
pubmed: 16059734
J Pharmacol Exp Ther. 2004 Jan;308(1):47-53
pubmed: 14532354
J Urol. 2005 Jun;173(6):2178-81
pubmed: 15879883
Pharmacology. 1990;40(2):110-21
pubmed: 2345772
J Pharmacol Exp Ther. 2014 Jan;348(1):25-31
pubmed: 24144794
Auton Autacoid Pharmacol. 2006 Jul;26(3):303-9
pubmed: 16879496
Physiol Res. 2016 Oct 24;65(Suppl 3):S391-S399
pubmed: 27775424
J Pharmacol Exp Ther. 1998 Oct;287(1):137-43
pubmed: 9765332
J Cardiovasc Pharmacol. 1990 Aug;16(2):239-48
pubmed: 1697380
J Heart Valve Dis. 2004 Sep;13(5):798-803
pubmed: 15473483
Front Pharmacol. 2019 Aug 16;10:911
pubmed: 31474866
Naunyn Schmiedebergs Arch Pharmacol. 2003 May;367(5):524-31
pubmed: 12669188
Diabetologia. 1992 Nov;35(11):1011-9
pubmed: 1473611
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1586-97
pubmed: 19270193
Eur J Pharmacol. 2009 Mar 15;606(1-3):191-8
pubmed: 19374847
Zoolog Sci. 2002 Feb;19(2):167-74
pubmed: 12012779
Naunyn Schmiedebergs Arch Pharmacol. 2015 Oct;388(10):1119-20
pubmed: 26278281
J Auton Nerv Syst. 1990 Apr;30(1):1-11
pubmed: 2348050
J Pharmacol Exp Ther. 2004 Jun;309(3):1148-53
pubmed: 14769832
J Pharmacol Exp Ther. 2007 Sep;322(3):998-1002
pubmed: 17596535
Nat Methods. 2015 Mar;12(3):179-85
pubmed: 25719825
Cardiovasc Res. 1997 Apr;34(1):145-56
pubmed: 9217884
Br J Pharmacol. 2010 Aug;160(7):1577-9
pubmed: 20649561
Physiol Genomics. 2010 Nov 29;42A(4):244-58
pubmed: 20841496
J Vasc Res. 2018;55(3):177-186
pubmed: 29975955
Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):215-24
pubmed: 24213882
J Pharmacol Methods. 1980 Dec;4(4):313-26
pubmed: 7206739
Pharmacol Res. 2000 Feb;41(2):201-9
pubmed: 10623488
Front Pharmacol. 2011 Feb 25;2:11
pubmed: 21687506
Toxicol Appl Pharmacol. 1998 Feb;148(2):245-51
pubmed: 9473532
Am J Physiol Regul Integr Comp Physiol. 2003 Sep;285(3):R701-8
pubmed: 12763741
J Physiol Pharmacol. 2009 Jun;60(2):21-7
pubmed: 19617641
Am J Physiol Heart Circ Physiol. 2004 Feb;286(2):H667-76
pubmed: 14715500

Auteurs

Betul R Erdogan (BR)

Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Irem Karaomerlioglu (I)

Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Zeynep E Yesilyurt (ZE)

Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Nihal Ozturk (N)

Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

A Elif Muderrisoglu (AE)

Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Martin C Michel (MC)

Department of Pharmacology, Johannes Gutenberg University, Mainz, Germany. marmiche@uni-mainz.de.

Ebru Arioglu-Inan (E)

Department of Pharmacology, Faculty of Pharmacy, Ankara University, Ankara, Turkey.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH